MYP_040729
Basic Information
Tirzepatide
Hormonal / Endocrine Hormone peptide
Metabolic Glucose metabolism Antidiabetic
not Standard
39 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0218398 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
Insulin
32630
Structure & Mods
linear peptide/protein therapeutic [Linear]
noncanonical stereochemical or chemical modification [Modified]
Ambiguous/noncanonical residue symbol X present in deposited sequence
Bio-Activity Profile
Hormone replacement
,The half-life is approximately five days.
RECORD: Rec_0400054 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GIP/GLP-1 dual agonist
9606;32630
Structure & Mods
branched peptide architecture [Branched]
mixed L/D amino-acid peptide [Mixed]
Amidation
Non-standard residues/X at 2, 13; Lipidation
Bio-Activity Profile
Antidiabetic Weight management GIP receptor agonist GLP-1 receptor agonist
Human GIP receptor and GLP-1 receptor
Clinical/Human: Approximately 5 d